Updates are available Correction dated 2020-09-28
Click to view Correction: https://doi.org/10.1186/s13601-020-00343-w
-
Authors
Hox, Valerie http://orcid.org/0000-0003-2390-294X
Lourijsen, Evelijn
Jordens, Arnout
Aasbjerg, Kristian
Agache, Ioana
Alobid, Isam
Bachert, Claus
Boussery, Koen
Campo, Paloma
Fokkens, Wytske
Hellings, Peter
Hopkins, Claire
Klimek, Ludger
Mäkelä, Mika
Mösges, Ralph
Mullol, Joaquim
Pujols, Laura
Rondon, Carmen
Rudenko, Michael
Toppila-Salmi, Sanna
Scadding, Glenis
Scheire, Sophie
Tomazic, Peter-Valentin
Van Zele, Thibaut
Wagenmann, Martin
van Boven, Job F. M.
Gevaert, Philippe
-
Funding
Funding for this research was provided by:
European Academy of Allergy and Clinical Immunology (Task Force budget)
- License Information
-
More Information
Article History
Received: 30 November 2019
Accepted: 2 December 2019
First Online: 3 January 2020
Change Date: 28 September 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: GS: Honoraria for articles, speaker and advisory boards: ALK, Astra Zeneca, Brittania Pharmaceuticals, Capnia, Church & Dwight, Circassia, Groupo Uriach, GSK, Meda/Mylan, Merck, MSD, Ono Pharmaceuticals, Oxford Therapeutics, Sanofi-Aventis, UCB. Travel funding: ALK, Bayer, GSK, Meda. Chair of BSACI Rhinitis guidelines, EAACI Ethics Committee, Rhinology & Laryngology Research Fund. Chair of Data Monitoring Board for Acarizax paediatric AR trial.CH: Reimbursed for Advisory Board work for sanofi, Smith and Nephew and speakers bureau for Medtronic.CB: Advisory board of Sanofi, GSK, Novartis, Astra-Zeneca, Mylan and reimbursed for presentations and travel.TVZ: Consultant for Medtronic and 3NT.STS: has acted as paid consultant for ERT and Roche Products. All these are outside the submitted work.All other authors declare that they have no competing interests.
